Global Coronavirus Diagnostics Market Size study, by Type of Test (Molecular and Serology), by End-User (Hospitals, Public Health Labs, Private or Commercial Labs, Physician Labs and Others) and Regional Forecasts 2020-2026

Global Coronavirus Diagnostics Market is valued approximately at USD XX million in 2019 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2020-2026. The emerging pandemic, novel coronavirus disease (COVID-19) is caused by SARS-COV-2 and spreads from animals to humans, and from humans to humans in general. Typically, the virus travels from the infected person's blood droplets, or the infected person's nose discharges as they cough or sneeze. First case of the disease was identified in Wuhan, China in December 2019 and since then it has spread to millions of infected areas of the world. As of 9 April 2020, the estimated number of cases of coronavirus reached 1.5 million worldwide, some 330,000 of them had survived and more than 88,000 individuals had died. A significant number of patients infected by COVID-19 reported fever and acute respiratory symptoms, according to the US Centers for Disease Control and Prevention. Findings were obtained from laboratory or clinical experiments performed on patients in the initial phase of the viral infection, centered in various countries. Specimens obtained from the blood of patients living in various regions showed a drop in the number of lymphocytes in the white blood cell count. However, the blood samples collected from critically ill patients showed a steady as well as a substantial decrease in the number of lymphocytes in the blood and an increase in the abundance of D-dimer. The diagnosis of the novel coronavirus is predictive, and for subjects diagnosed with acute coronavirus infection oxygen therapy is a key medical procedure towards the diagnosis. In addition, at the time of oxygen therapy, automatic ventilation may be used during respiratory collapse, and hemodynamic assistance is required to manage septic shock skillfully. By providing safe automatic ventilation and non-invasive ventilation or high flow nasal oxygen, respiratory failure may be treated as per WHO's guidance of 28 January 2020. The UN's public health body has approved the inoculation and consumption of Lopinavir / ritonavir alpha-interferon, or drug.

The regional analysis of Coronavirus Diagnostics market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America contributes substantial share of the global market and anticipated a considerable growth rate over the forecast period due to developed medical infrastructure and favorable health insurance policies in most countries in the region and the involvement of the region's leading manufacturers.

Major market player included in this report are:

F. Hoffmann-La Roche AG

Bio-Rad Laboratories Inc.

Beckman Coulter Inc.

Becton, Dickinson and Company

Lonza Group

bioMérieux

Hologic, Inc.

QIAGEN

GlaxoSmithKline Biologicals SA

Abbott Laboratories

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type of Test:

Molecular

Serology

By End-User:

Hospitals

Public Health Labs

Private or Commercial Labs

Physician Labs

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

Asia Pacific

China

India

Japan

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2016, 2017, 2018

Base year – 20198

Forecast period – 2020 to 2026

Target Audience of the Global Coronavirus Diagnostics Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors